UniQure advanced ifezuntirgene inilparvovec (AMT-130), a gene therapy for Huntington disease (HD), toward potential US and UK ...

New approach that induces patients to make their own CAR-T cells could be faster and cheaper than existing methods ...

Targeted does not mean risk-free. Blocking an immune pathway can interfere with the body's ability to respond to infections. Depending on the medication, healthcare providers may monitor patients for ...

For years, the most effective psoriasis treatments meant regular biologic injections. That’s starting to change, however, as ...

Continuous caloric restriction or a keto diet combined with systemic therapy may improve psoriasis severity, according to a systematic review published in the Journal of Drugs in Dermatology. Research ...

Fernandez said triggers can include certain medications, a bacterial or viral infection, environmental exposures such as cold ...

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs i ...

Monoclonal Antibodies Market was valued at USD 280.15 billion in 2025 and is expected to reach USD 791.28 billion by 2035, growing at a CAGR of 11.01% from 2026-2035.

Biologic therapy may alter the gut microbiome in patients with autoimmune arthritis, with specific microbial patterns linked to treatment response.

Validated HPLC-MS, NMR and a validated cell-based biological potency assay using the U937 human cell line, with MIP-1β as a biological marker of Thykamine™'s anti-inflammatory activity, provide ...

Alumis said on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in ​a smaller subset of patients, even after the treatment failed ‌to meet the main goal of a ...

Though Alumis still sees a path forward in lupus, the result made its drug the latest TYK2 blocker to struggle in conditions beyond psoriasis and psoriatic arthritis.